Shankar Siva
Expertise in
8
conditions

Shankar Siva

305 Grattan St, 
Melbourne, VIC, AU 
Expertise in
8
conditions
305 Grattan St, 
Melbourne, VIC, AU 

Overview

Shankar Siva practices practicing medicine in Melbourne, Australia.

Mr. Siva is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Prostatectomy, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 374 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

305 Grattan St, Melbourne, VIC 3000, Australia
Other Locations
Locked Bag 5m A'Beckett St, Melbourne, VIC 8006, Australia
St Andrews Place, East Melbourne, VIC 3002, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial (FASTRACK II)
Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial (FASTRACK II)
Enrollment Status: Unknown
Publish Date: November 18, 2022
Intervention Type: Radiation
Study Phase: Phase 2
High Intensity Functional Image Guided Vmat Lung Evasion
High Intensity Functional Image Guided Vmat Lung Evasion
Enrollment Status: Completed
Publish Date: May 19, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomised Phase II Trial
Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomised Phase II Trial
Enrollment Status: Completed
Publish Date: November 04, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
A Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475.
A Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475.
Enrollment Status: Completed
Publish Date: October 18, 2017
Intervention Type: Radiation, Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

374 Total Publications

Does stereotactic ablative body radiotherapy (SABR) added to continued systemic therapy improve time to treatment failure compared with physician's choice of systemic therapy in oligoprogressive ER-positive, HER2-negative advanced breast cancer? Study protocol for a multicentre, randomised, open-label phase II trial in Australian tertiary cancer centres (AVATAR-II).
Does stereotactic ablative body radiotherapy (SABR) added to continued systemic therapy improve time to treatment failure compared with physician's choice of systemic therapy in oligoprogressive ER-positive, HER2-negative advanced breast cancer? Study protocol for a multicentre, randomised, open-label phase II trial in Australian tertiary cancer centres (AVATAR-II).
Journal: BMJ open
Published: September 03, 2026

Frequently Asked Questions about Shankar Siva

Is Shankar Siva a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Shankar Siva is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shankar Siva participate in research or clinical trials?

Yes. Shankar Siva has published 374 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Shankar Siva's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Siva's expertise for a condition
ConditionClose
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile